– The solution combines three medications delivering the broadest spectrum of protection
against internal and external parasites in cats.
– The solution is safe for cats from eight weeks of age in addition to pregnant and lactating
cats.
– The solution aims to ensure convenience for veterinarians, while ensuring cat owner
compliance and broad-spectrum protection for cats against parasite

Boehringer Ingelheim has launched a breakthrough monthly parasiticide solution for cats in the UAE, to ensure convenient and comprehensive protection for cats and cat owners.
The solution combines esafoxolaner for fleas and ticks, and eprinomectin and praziquantel for internal
parasites, delivering a broad-spectrum of protection against fleas, ticks, mites, worms, and other
parasites. The solution is safe for cats from eight weeks of age in addition to pregnant and lactating cats
and provides a one and done solution, ensuring convenience for veterinarians, cat owners and cats alike.
During the launch event, which took place on 30 September in the presence of over 100 veterinarians
from the UAE and beyond, Dr. Remo Lobetti, President of the European College of Veterinary
Internal Medicine and a renowned expert in small animal medicine, spoke about the significant health
risks that parasites pose to cats. He emphasized the importance of comprehensive protection, stating,
“Feline parasites can cause a variety of health issues, ranging from mild skin irritations to serious
diseases that affect multiple organs. While fleas are the most common parasite in cats, there are many
other internal parasites that go unnoticed but pose severe health risks. The new solution by Boehringer
Ingelheim is a groundbreaking solution addressing not just the visible signs but also the hidden threats,
offering cats all-round protection. It’s an innovative step forward in parasite control, providing much
needed peace of mind for veterinarians and cat owners.”
Gurkan Ulusoy, Head of Animal Health, Near East and UAE, at Boehringer Ingelheim, said,
“Contrary to popular belief, parasites are not limited to cats allowed outdoors. They can be found in dirt,
indoor and outdoor plants, shoes, and other animals. One of the main challenges in treating cats,
particularly here in the UAE, is ensuring that the treatment process is stress-free and convenient for both
pets and time-pressed owners. With the hot climate in the region, cats face especially high risk exposure
to a range of parasites year-round, not just during specific seasons. Boehringer Ingelheim has addressed
these concerns by offering a topical application that is easy to administer and provides comprehensive
protection. The convenience of the solution has the potential to create better compliance from pet owners,
ensuring domesticated cats remain protected”
The new solution by Boehringer Ingelheim is available by veterinarian prescription in the UAE, providing a
trusted solution for all cat owners to protect their pets against parasites. With its advanced formula and
convenient administration, the product represents a significant advancement in feline healthcare. Cat
owners are encouraged to consult their trusted veterinarians for more information on the various parasites
and their treatment.
The launch of the new solution is testament to Boehringer Ingelheim’s commitment to animal health
through detection, prevention, and treatment and adds to the company’s wide-ranging animal health
portfolio containing some of the most respected and widely used vaccines, parasiticides and therapeutics products. Over the past several decades, the global pharmaceutical leader has transformed the lives of animals and the people who care for them to help ensure no animal suffers from a preventable disease.

– The clinic develops a personalized treatment plan that includes a consultant in pediatric
gastroenterology and nutrition, pediatric clinical psychologist, occupational therapy, speech and
language pathology and nutritional counseling
– Holistic approach focuses on child’s medical, nutritional, feeding ability and psychological
wellbeing — meaning mealtime battles may become a thing of the past
– It caters to all feeding issues from extreme pickiness to sensory issues or tube feeding
dependence for children with wider health or medical condition

Danat Al Emarat Hospital for Women & Children, part of the M42
group, has launched a comprehensive feeding clinic designed to address a variety of feeding challenges
in children, including extreme pickiness. This means mealtime battles may soon become a thing of the
past – reducing stress for the whole family.
Children across the globe go through a picky eating phase between the ages of two and five, but this can
begin even earlier. From unusual behaviors, picky eating and swallowing safely to restricted diets, it may
be a struggle for both parents and the child. Danat Al Emarat Hospital for Women & Children’s new
comprehensive feeding clinic is more than just teaching children to eat appropriately; its primary
purpose is to help children and their families develop effective feeding behaviors and patterns.
Working closely with the families, specialists at Danat Al Emarat Hospital for Women & Children will
determine the difficulties in feeding and develop personalized, strategic, and specific therapies to
support in this journey. The comprehensive feeding clinic’s team of experts includes pediatric
gastroenterologists, speech and language pathologists, psychologists and dietitians who collaborate to
create personalized plans to help children overcome mealtime struggles. Together, they will offer
comprehensive evaluations and support for issues such as extreme pickiness, difficulty chewing or
swallowing, sensory issues, tube-feeding dependence, and pain or discomfort while eating.
Taking a holistic approach centered on the child’s medica and nutritional needs, feeding abilities, and
psychological well-being, the clinic aims to streamline the treatment journey and enhance outcomes for
young patients and their families. This includes catering to the needs of all children, including those with
chromosomal abnormalities, congenital heart disease, cerebral palsy, autism spectrum disorders, and
various gastrointestinal problems, including reflux and eosinophilic esophagitis.
Dr. Ala Shaikh Khalil, Consultant Pediatric Gastroenterologist at Danat Al Emarat Hospital for Women &
Children said, “We’ve noticed that many of our patients struggle with feeding problems. We understand
that mealtimes can be a source of frustration and stress when children are very picky or have feeding
and swallowing difficulties. This is why our team created the comprehensive feeding clinic. Issues range from difficulty handling certain textures to more severe problems like food entering the lungs instead of the GI tract, which often requires tube feeding.”
“Feeding problems in young children are complex and require an interdisciplinary approach. Our
patient-centered approach works closely with families throughout the treatment process to help
achieve the best outcomes. Having all the support available at Danat Al Emarat ensures that families get
a full continuum of care. This means all the support they need is all available in one place, with a unified
set of recommendations, after telling their story just once,” Dr. Ala added.
Crucial psychological support
Dr. Summia Zaher, Chief Executive Officer and Consultant, Obstetrics & Gynecology Danat Al Emarat
Hospital for Women & Children said, “In our commitment to enriching the lives of the families in our
care, Danat Al Emarat Hospital for Women &  Children is delighted to launch our new specialized clinic
dedicated to addressing childhood feeding challenges. We understand the profound importance of
nurturing not only our children’s physical health but also their emotional and psychological well-being.
Our goal is to make feeding both safe and pleasurable for the child and their family.”
Dr. Ala emphasized the importance of a personalized treatment plan. She said, “We assess each child to
ensure there are no undiagnosed medical issues, optimize their nutrition, ensure safe and efficient
feeding practices and provide crucial psychological support to both the child and their family.”

– Groundbreaking ceremony marks Amana Healthcare’s entry into Bahrain and commitment to
delivering specialized care for the Kingdom’s people

– New facility will be the Kingdom’s first specialized long-term care provider offering post-acute
rehabilitation services
Operations scheduled to commence in 2025, Recruitment Day on 12 October in Manama will
employ the Kingdom’s most skilled local professional

Amana Healthcare, part of the M42 group, in
partnership with Bahrain Mumtalakat Holding Company (“Mumtalakat”), celebrated a groundbreaking
ceremony on 18 September 2024 to mark the start of construction on the Amana Healthcare facility in
Al Jasra, Bahrain. This milestone signifies Amana Healthcare’s entry into Bahrain and its commitment to
delivering world-class health solutions and specialized care for the health and wellbeing of people in the
Kingdom.
Members of Amana Healthcare – Bahrain’s Board of Directors attended the ceremony, including Dr.
Mohamed AlSaati, Acting CEO of M42 Bahrain and CEO of Amana Healthcare Bahrain and Khalid Hussain
Taqi, Managing Director – Local Impact Investments at Mumtalakat.
Commenting on the occasion Dr. AlSaati said, “This highly specialized new facility will address a critical
need in Bahrain, particularly long-term complex medical needs and post-acute rehabilitation. We are
proud to be partnering with Mumtalakat to address crucial gaps in the healthcare landscape, support
the vision of the country and create jobs for Bahrainis. The groundbreaking will mark the first step in this
journey, with momentum maintained through a Recruitment Day on 12 October 2024 in Manama to
engage and recruit the Kingdom’s most skilled local professionals. We’re looking forward to seeing
Amana Healthcare take shape in Bahrain ready to positively impact people in the Kingdom.”
Mr. Taqi added: “Mumtalakat is committed to investing in key sectors of Bahrain’s economy to benefit
and enrich the lives of its people. The launch of Amana Healthcare will allow us to leverage M42’s
expertise in delivering world-class care, ensuring that technology and innovation are at the forefront of
one of the most vital sectors – healthcare. The groundbreaking ceremony marks the start of the project,
which will ensure the efficient use of resources and further elevate the accessibility and quality of
healthcare provided to all citizens and residents. Furthermore, this aligns with our mandate to create
sustainable, long-term partnerships that deliver valuable services, while creating highly skilled job
opportunities.”
Scheduled to commence operations in 2025, the new facility will be the first international premium
provider of specialized long-term care and post-acute rehabilitation services in Bahrain – an innovative
approach set to revolutionize healthcare in the region and beyond.

The 15,000-square-meter, 100-bed facility will feature two large gyms, a hydrotherapy pool, two
majlises and gardens. The facility aims to offer world-class, tech-enabled services across its three wings.